Portfolio company
Envisagenics
United States
Raised
Undisclosed
Latest stage
Series B
Rounds recorded
2 · 2 undisclosed
Backed by
2 investors
Sectors
About
This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.
SourceFunding history · 2
Similar companies
Insilico Medicine
This company develops artificial intelligence platforms for drug discovery and design to serve pharmaceutical and biotechnology organisations.
Atomic AI
This company develops artificial intelligence platforms for RNA-targeted drug discovery to assist biotechnology and pharmaceutical organisations with medicine development.
Ingenix
This company develops an artificial intelligence system that integrates biological data to support drug development decisions for pharmaceutical and biotechnology organisations.
Biorelate
This company develops an artificial intelligence platform that curates biomedical data to support drug discovery for pharmaceutical and life sciences organisations.
Enveda
This biotechnology company develops pharmaceutical drug candidates for patients with inflammatory and metabolic diseases using an artificial intelligence platform to decode plant chemistry.
Relation Therapeutics
This biotechnology firm develops an artificial intelligence platform to identify and validate therapeutic drug targets for pharmaceutical companies and research partners.
Phenomic AI
This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.
Fauna Bio
This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.
